past
year
effort
made
toward
better
understand
health
statu
anim
popul
particularli
regard
viral
infect
due
high
mutat
rate
replic
strategi
virus
respons
recent
recogn
emerg
diseas
pose
danger
domest
wild
anim
also
human
high
densiti
domest
stray
anim
urban
area
enabl
viral
dissemin
mainten
popul
consequ
anim
act
reservoir
diseas
possibl
transmiss
wildlif
popul
occasion
contact
canin
parvoviru
cpv
first
identifi
late
respons
sever
hemorrhag
gastroenter
myocard
dog
parvovirus
extrem
stabl
environ
indirect
transmiss
assum
critic
role
spread
mainten
viru
anim
popul
especi
wild
carnivor
contact
rate
anim
lower
shortli
initi
detect
replac
two
antigen
variant
recent
third
variant
describ
canin
distemp
viru
cdv
etiolog
agent
canin
distemp
highli
contagi
diseas
respons
high
mortal
rate
dog
worldwid
sequenc
analysi
cdv
strain
origin
differ
geograph
area
sever
anim
speci
show
hemagglutinin
gene
undergon
genet
drift
accord
geograph
locat
phylogenet
analysi
base
gene
reveal
exist
least
nine
strain
differ
geograph
area
name
america
european
wildlif
arcticlik
south
america
southern
africa
canin
coronaviru
ccov
caus
mild
moder
enter
dog
infect
character
high
morbid
low
mortal
ccov
transmit
faecalor
rout
spread
rapidli
group
suscept
anim
stress
environ
larg
concentr
anim
poor
hygien
condit
often
seen
kennel
favour
develop
diseas
although
higher
mortal
rate
observ
anim
multipl
infect
pathogen
canin
adenoviru
type
cdv
ccov
repres
per
si
major
infecti
agent
respons
sever
epidem
virolog
survey
conduct
throughout
world
allow
detect
analysi
larg
varieti
virus
differ
anim
popul
cape
verd
archipelago
knowledg
similar
studi
conduct
far
order
detect
presenc
canin
virus
maio
island
sampl
collect
stray
dog
vila
maio
test
canin
parvoviru
cpv
canin
distemp
viru
cdv
canin
coronaviru
ccov
estim
viral
preval
popul
investig
role
anim
mainten
potenti
spread
common
viral
pathogen
record
avail
specimen
sampl
dog
undetermin
mix
breed
femal
male
dog
data
regist
regard
gender
diaharr
feac
describ
anim
two
dog
vaccin
vaccin
inform
regard
vaccin
rest
anim
avail
na
percentag
posit
cpvdna
similar
sampl
respect
sera
sampl
collect
test
posit
cpv
antibodi
anim
includ
first
elisa
unit
eu
class
eu
second
eu
class
eu
third
eu
class
eu
tabl
antibodi
cpv
detect
anim
age
less
month
dog
age
month
year
dog
year
dog
year
dog
year
dog
older
year
figur
proport
seroposit
anim
significantli
higher
older
anim
p
differ
found
seropreval
gender
p
sampl
test
virolog
serolog
posit
cpvdna
seroposit
dog
excret
viru
time
collect
seroneg
cpv
specif
igg
regard
sampl
test
cdvrna
n
anim
posit
also
coinfect
cpv
sampl
found
cdvrna
neg
serolog
anim
sampl
seroposit
cdv
two
group
identifi
accord
antibodi
ab
titer
low
ab
titer
iif
valu
n
medium
ab
titer
iif
valu
n
antibodi
cdv
detect
anim
age
less
month
dog
age
month
year
dog
year
dog
year
dog
year
dog
older
year
sampl
figur
although
linear
increas
seroposit
anim
age
associ
statist
signific
p
presenc
antibodi
independ
gender
p
two
sampl
collect
year
survey
test
posit
ccovrna
studi
describ
first
time
shed
three
common
enter
canin
virus
cpv
cdv
ccov
stray
dog
vila
maio
cape
verd
report
data
cpv
cdv
seropreval
sampl
collect
two
consecut
year
similar
frequenc
posit
cpv
anim
found
name
probabl
reflect
high
environment
resist
cpv
viral
transmiss
spread
cpv
occur
easili
without
direct
contact
anim
viru
shed
high
titr
faec
excret
period
may
last
longer
allow
higher
opportun
contact
viru
new
host
although
posit
dog
show
signal
diarrhoea
recov
anim
may
also
serv
asymptomat
reservoir
shed
viru
period
contribut
persist
continu
circul
cpv
environ
alreadi
report
cat
also
cpv
resist
environment
condit
may
explain
high
seropreval
obtain
similar
report
studi
conduct
nonvaccin
dog
popul
vast
major
posit
sampl
present
high
antibodi
titer
n
tabl
even
though
could
correl
hemagglutin
inhibit
valu
gold
standard
assay
titrat
cpv
antibodi
howev
possibl
perform
assay
observ
suggest
persist
viru
environ
accord
high
percentag
carrier
anim
found
within
anim
sampl
type
obtain
cpvdna
detect
seroposit
dog
shed
viru
circul
antibodi
possibl
anim
earli
stage
infect
primari
igm
investig
elisa
kit
use
studi
specif
igg
detect
seropreval
cpv
significantli
higher
older
anim
p
probabl
reflect
high
likelihood
viru
exposur
time
moreov
younger
dog
suscept
viru
succumb
diseas
therefor
remov
popul
progress
evolut
led
emerg
three
antigen
variant
differ
properti
origin
strain
monitor
preval
differ
cpv
cape
verd
archipelago
would
import
assess
distribut
viral
variant
geograph
locat
also
understand
evolutionari
pattern
viru
circunscript
popul
addit
given
high
nucleotid
substitut
rate
cpv
similar
rna
virus
terrain
characterist
cape
verd
island
possibl
transport
peopl
good
infect
anim
consid
preval
cdv
detect
realtim
pcr
sampl
cdvrna
neg
interestingli
year
seropreval
obtain
viru
anim
nonvaccin
explan
seroposit
may
lie
previou
contact
viru
ill
anim
could
occur
previou
year
sever
factor
may
explain
absenc
cdv
shed
faec
dog
sampl
take
account
cdv
poor
resist
dri
hot
environ
possibl
viru
resist
cape
verd
summer
high
temperatur
reduc
opportun
dog
expos
viru
addit
high
mortal
rate
caus
cdv
contribut
low
viru
spread
canin
popul
sinc
anim
succumb
infect
stop
shed
hand
anim
densiti
citi
low
compar
larger
citi
less
contact
rate
anim
affect
viru
mainten
spread
still
anim
anticdv
antibodi
compar
presenc
antibodi
age
dog
linear
increas
seropreval
age
found
may
relat
possibl
past
cdv
outbreak
popul
although
statist
signific
higher
seropreval
older
dog
alreadi
report
presenc
cdv
antibodi
associ
gender
cdv
seroposit
anim
show
protect
antibodi
titer
accord
twark
dodd
establish
comparison
serum
neutral
iif
assay
although
anim
low
antibodi
titer
tabl
schultz
et
al
report
activ
immun
dog
either
natur
vaccin
antibodi
titer
relev
provid
detect
nevertheless
despit
good
sensit
specif
elisa
would
advis
test
sampl
use
serum
neutral
test
confirm
presenc
titer
neutral
antibodi
fulli
assess
immun
statu
anim
popul
relat
genet
variabl
cdv
would
interest
identifi
differ
cdv
genotyp
posit
sampl
order
differenti
vaccin
field
strain
determin
lineag
circul
island
regard
ccov
found
low
preval
agreement
similar
survey
conduct
area
similar
characterist
vila
maio
dog
popul
low
preval
may
indic
low
viral
circul
probabl
due
viru
instabl
normal
environment
condit
also
reduc
number
viral
particl
faec
cpv
dog
recov
ccov
infect
may
function
asymptomat
reservoir
shed
viru
period
result
persist
continu
circul
ccov
environ
avail
data
concern
epidemiolog
mechan
ccov
suggest
environ
provid
kennel
fundament
maintain
infect
canin
popul
seropreval
ccov
perform
due
rapid
decay
antibodi
caus
natur
exposur
moreov
avail
serolog
assay
base
identif
antibodi
ccovii
efficaci
unknown
detect
ccovi
antibodi
question
use
method
result
present
studi
demonstr
cpv
cdv
ccov
circul
canin
popul
vila
maio
cape
verd
presenc
suscept
anim
high
frequenc
infect
prolong
period
viru
shed
environment
persist
agent
especi
cpv
contribut
continu
circul
popul
thu
inform
regard
spatial
distribut
circul
virus
risk
factor
associ
infect
definit
facilit
plan
control
strategi
knowledg
vaccin
program
undertaken
region
implement
could
contribut
increas
immun
popul
reduc
viral
circul
consequ
decreas
popul
suscept
futur
diseas
outbreak
addit
absenc
control
measur
may
increas
risk
pathogen
spill
either
suscept
newcom
host
resid
suscept
new
host
sympatr
carnivor
speci
due
wide
rang
cpv
cdv
suscept
host
would
import
identifi
maio
island
wildlif
assess
potenti
risk
infect
speci
sampl
conduct
vila
maio
locat
maio
island
cape
verd
neuter
health
surveil
program
develop
veterinarian
without
frontier
portug
vsf
two
distinct
period
collect
rectal
swab
anim
includ
blood
sampl
n
rectal
swab
n
anim
tabl
biolog
sampl
store
refriger
process
rectal
swab
homogen
pb
centrifug
min
supernat
collect
store
blood
sampl
centrifug
min
separ
plasma
blood
cell
plasma
store
process
viral
nucleic
acid
extract
supernat
rectal
swab
process
qiamp
minelut
qiagen
germani
accord
manufactur
instruct
viral
dna
rna
coextract
although
use
commerci
kit
co
extract
viral
nucleic
acid
nonrecommend
biolog
matrix
may
impli
reduc
nucleic
acid
yield
suffici
experi
detect
viral
nucleic
acid
use
realtim
pcr
qpcr
realtim
rtpcr
rt
qpcr
cpv
dna
amplifi
qpcr
use
gene
express
master
mix
appli
biosystem
cdv
ccov
rna
amplifi
rtqpcr
use
rnatoct
tm
step
kit
reaction
ng
templat
primer
probe
calcul
use
primer
design
tool
ncbi
http
wwwncbinlmnihgovtoolsprimerblast
cpv
primer
base
nucleotid
sequenc
gene
avail
access
number
cdv
primer
chosen
within
nucleocapsid
gene
ccov
primer
target
highli
conserv
gene
alreadi
describ
tabl
final
concentr
nm
forward
primer
nm
revers
primer
nm
probe
use
tabl
amplif
perform
stepon
plu
thermocycl
appli
biosystem
cycl
condit
compris
initi
denatur
step
minut
follow
cycl
second
minut
templat
rna
amplif
cycl
includ
revers
transcript
step
minut
cpv
tenfold
dilut
cornel
strain
merial
use
posit
control
regard
cdv
bp
fragment
includ
target
region
amplifi
cdv
rna
merial
clone
teasi
vector
promega
accord
manufactur
instruct
cdv
recombin
plasmid
use
posit
control
similar
approach
use
ccov
alreadi
describ
assay
specif
confirm
direct
sequenc
cpv
amplicon
cdv
ccov
sequenc
perform
plasmid
clone
cross
reactiv
detect
cdvccovcpv
sensit
rtqpcrqpcr
three
agent
surpass
detect
target
assess
convers
posit
control
mass
base
follow
formula
number
copi
mass
number
base
pair
x
bp
x
avogadro
number
x
antibodi
ab
detect
perform
serum
sampl
cpv
cdv
use
indirect
elisa
kit
ingezim
canin
parvo
ingezim
moquillo
specif
igg
detect
accord
manufactur
instruct
method
allow
quantif
ab
titer
cpv
use
formula
provid
kit
although
specifi
correspond
hemagglutin
inhibit
assay
quantif
anticpv
antibodi
valu
organ
three
class
elisa
unit
eu
eu
eu
cdv
od
valu
correspond
indirect
immunofluoresc
iif
method
valu
divid
three
categori
low
titer
iif
valu
medium
titer
iif
valu
high
titer
iif
valu
possibl
associ
serolog
find
age
gender
anim
determin
chisquar
statist
test
ibm
spss
statist
softwar
p
valu
consid
signific
author
declar
compet
interest
pc
ad
lt
respons
concept
studi
design
activ
particip
analysi
data
interpret
pc
ad
also
involv
draft
revis
articl
sg
cc
involv
data
analysi
mm
sv
respons
organ
field
work
sampl
collect
